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Summary
The aim of this study was to evaluate a number of foot-and-mouth disease
(FMD) test methods for use in red deer. Ten animals were intranasally inoculated
with the FMD virus (FMDV) O UKG 11/2001, monitored for clinical signs, and
samples taken regularly (blood, serum, oral swabs, nasal swabs, probang samples
and lesion swabs, if present) over a 4-week period. Only one animal, deer 1103,
developed clinical signs (lesions under the tongue and at the coronary band of
the right hind hoof). It tested positive by 3D and IRES real-time reverse tran-
scription polymerase chain reaction (rRT-PCR) in various swabs, lesion materials
and serum. In a non-structural protein (NSP) in-house ELISA (NSP-ELISA-IH),
one commercial ELISA (NSP-ELISA-PR) and a commercial antibody NSP pen
side test, only deer 1103 showed positive results from day post-inoculation (dpi)
14 onwards. Two other NSP-ELISAs detected anti-NSP serum antibodies with
lower sensitivity. It also showed rising antibody levels in the virus neutralization
test (VNT), the in-house SPO-ELISA-IH and the commercial SPO-ELISA-PR at
dpi 9, and in another two commercial SPO-ELISAs at dpi 12 (SPO-ELISA-IV)
and dpi 19 (SPO-ELISA-IZ), respectively. Six of the red deer that had been rRT-
PCR and antibody negative were re-inoculated intramuscularly with the same
O-serotype FMDV at dpi 14. None of these animals became rRT-PCR or NSP-
ELISA positive, but all six animals became positive in the VNT, the in-house
SPO-ELISA-IH and the commercial SPO-ELISA-PR. Two other commercial
SPO-ELISAs were less sensitive or failed to detect animals as positive. The rRT-
PCRs and the four most sensitive commercial ELISAs that had been used for the
experimentally inoculated deer were further evaluated for diagnostic specificity
(DSP) using 950 serum samples and 200 nasal swabs from non-infected animals.
DSPs were 100% for the rRT-PCRs and between 99.8 and 100% for the ELISAs.
Introduction
Foot-and-mouth disease is a highly contagious viral disease
of cloven-hoofed animals and is endemic or sporadic in
many countries worldwide. The causative agent, the FMD
virus, consists of seven antigenically distinct serotypes (O,
A, C, Asia 1, SAT 1, SAT 2 and SAT 3). The impact of FMD
for a country’s international trade is very high. Conse-
quently, rapid and accurate laboratory diagnosis is essential
for confirmation and typing of the virus present in any sus-
pected clinical case (Alexandersen et al., 2003a,b).
Naturally occurring FMD in red deer (Cervus elaphus
elaphus) has been reported (Forman and Gibbs, 1974).
However, FMDV-infected deer often do not show clinical
signs. Deer remain active and appear normal, even though
they may carry and excrete the virus (Forman and Gibbs,
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1974; Forman et al., 1974; Gibbs et al., 1975; McVicar
et al., 1974). The lack of significant clinical signs in deer
makes FMD laboratory testing a crucial tool for the identi-
fication of infection in farmed deer.
Even though FMD test methods are well evaluated for
cattle, and to a satisfactory extent for sheep, goats and pigs
(Alexandersen et al., 2003a,b, Brocchi et al., 2006), no test
method evaluation data are available for red deer and only
very limited data have been published for other deer species.
The aim of this study was therefore to evaluate FMD test
methods for use in red deer, which is the predominant deer
species farmed in New Zealand. These tests will improve
diagnostic capability for this high impact disease during
investigations and responses, if the need ever arises. Clinical
samples (positive control reagents) collected from red deer
are required for proper validation of any diagnostic assay
for the detection of FMDV and antibodies to the virus in
these animals.
Materials and Methods
Animal experiments
The animal experiments were performed within a high con-
tainment facility at the National Centres for Animal Disease
(NCAD) – Winnipeg Laboratory [National Centre for For-
eign Animal Disease (NCFAD)], Winnipeg, Manitoba,
Canada, with the approval of the institutional Animal Care
Committee under the close supervision of a veterinarian.
Ten red deer had been purchased from a red deer farm in
Ontario and transported to the NCFAD, Winnipeg, Mani-
toba. They were five male and five female red deer, aged
between 8 and 18 months and weighing between 35 and
80 kg. Six red deer were housed in two groups of three ani-
mals per cubicle. The remaining four were housed as two
groups of two in a double sized cubicle divided by puck
board and black mesh extending from floor to ceiling.
The inoculum (FMDV strain O UKG 11/2001) was pro-
duced from a seed stock originating from the Pirbright
Institute, UK, by passaging the virus twice in lamb kidney
(LK) cells. The P1 region of progeny virus was sequenced
and compared to an original field isolate GenBank Acces-
sion number DQ404180 (Cottam et al., 2006) to confirm
the absence of sequence changes in the P1 region, specifi-
cally where the determinant of the receptor cell tropism of
FMDV is contained, particularly VP2 and VP3. After pre-
sampling, every animal received an intranasal inoculation
of 106 50% tissue culture infective dose (TCID50) of the
FMD virus strain O UKG 11/2001 and diluted in a total
volume of 5 ml per animal (2.5 ml per nostril) in alpha
minimal essential medium (a-MEM). Following inocula-
tion, deer were monitored for clinical signs of disease and
their rectal temperatures and progression of disease
recorded regularly.
Animals were anaesthetized with 0.5–1.0 mg/kg of
xylazine intramuscular (via dart gun) and were then given
1–2 mg/kg ketamine intravenous as needed to prolong
sedation. Sedation was reversed with yohimbine at 0.1–
0.2 mg/kg half the volume given intravenous and half given
intramuscular. To minimize the amount of anaesthetics
received by individual animals, close examination and sam-
pling were scheduled on alternate days, giving each animal
at least 2 days between manipulations. Deep rectal temper-
atures (both baseline and post-infection) were taken using
a probe and recorded while the deer were recumbent under
sedation. At the end of the experimental infection period,
animals were euthanized using sodium pentobarbital.
It became apparent, following a preliminary analysis of
the virus and antibody detection data, that re-inoculation
of a subset of animals was necessary to generate sufficient
clinical material and positive serum samples. At 14 dpi, 6
of 9 red deer were therefore re-inoculated with 108 TCID50
of FMDV strain O UKG 11/2001 in a total volume of 1 ml
per animal, this time by intramuscular injection. Animals
that had no detectable virus in swabs or blood and no anti-
body response at the time were selected for re-inoculation.
Sample collection from experimental deer
Heparinised (whole) blood and clotted blood (for serum),
oesophageal–pharyngeal (probang) samples and swabs
(oral and nasal) were collected from all animals just before
inoculation and every 2 to 3 dpi per animal according to a
predetermined schedule.
Probang samples were diluted in an equal volume of
Eagle’s–HEPES medium (pH 7.2) containing 5% foetal calf
serum and stored at 70°C until required.
One deer, animal 1097, exhibiting mild signs consistent
with FMD was euthanized at 5 dpi and various tissue sam-
ples collected for virus detection and/or histopathology.
Tissues collected for histopathology included lymph nodes
(cervical, submandibular), lung, liver, spleen, tonsil, coro-
nary band, tongue, heart and nasopharynx/soft palate.
Tissues were immediately fixed in 10% formalin (formal-
FIXXTM, Thermo Fisher Scientific Inc., Waltham, MA,
USA) for at least 24 h or separately placed in transport
media.
At 14 dpi and following re-inoculation, blood, probang
and swabs were collected (as described earlier) from all ani-
mals every 2–3 days until 26/12 dpi (12 days post-re-inoc-
ulation) and on the day of post-mortem examination.
Three deer were then euthanized at 28/14 dpi, 2 at 29/
15 dpi, the final 4 at 30/16 dpi and tissue samples collected
and preserved as described earlier.
For tissue homogenate preparation, samples were rinsed
with Dulbecco’s PBS (D-PBS) to obtain rid of residual
transport medium, weighed and emulsified to obtain a
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10% weight/volume suspension in D-PBS. The suspension
was then clarified by centrifugation at 2000 g for 20 min at
4°C and the supernatant treated with antibiotics for
30 min at room temperature.
Sample collection from non-infected red deer
Collection of samples from non-infected New Zealand red
deer was performed at a number of slaughter plants
throughout New Zealand by Ministry for Primary Industries
(MPI) meat inspectors. FMD has never occurred in New
Zealand. A total of 950 blood samples were collected into
10-ml blood tubes with clotting agent. Another 200 blood
samples and matching 200 nasal swabs were also collected.
Bloods and swabs were couriered chilled to the Animal
Health Laboratory (AHL), Upper Hutt, New Zealand.
Bloods were spun at the laboratory and serum collected, ali-
quoted and stored frozen. The 950 serum samples were used
for testing in various ELISAs; the 200 extra serum samples
and 200 nasal swab samples were used for rRT-PCR testing.
Virus isolation
Isolation of FMDV from blood, swabs, probang samples,
vesicular fluid and 10% tissue homogenates was carried out
in primary LK cells and performed according to a pub-
lished protocol (Moniwa et al., 2012).
FMDV RNA detection
RNA extraction from blood, serum, nasal swabs, oral
swabs, probang samples and tissue homogenates for viral
RNA detection was performed using a MagMax-96 Viral
RNA Isolation Kit, AM1836 (Ambion, Life Technologies)
following manufacturer’s protocol. The MagMAXTM
Express-96 Instrument was used for purification using a
Deep Well Magnetic Particle Processor (Life Technologies).
Fifty five licrolitre of each sample was used for extraction
and the RNA eluted into 90 ll of Elution buffer.
Detection of viral RNA using FMDV 3D TaqMan rRT-
PCR was carried out according to a published protocol
(Moniwa et al., 2007). This rRT-PCR used primers and
probe that specifically target a conserved region of the
FMDV 3D gene resulting in the amplification of an 88 bp
product. The forward primer FMDV 1186F (50ACT
GGGTTTTAYAAACCTGTGATG30) and reverse primer
FMDV 1237R (50TCAACTTCTCCTKGATGGTCCCA30)
were custom made by Invitrogen (Life Technologies Inc.,
Burlington, ON, Canada). The FMDV TaqMan probe
(50ATCCTCTCCTTTGCACGC30) labelled on the 50 end
with 60FAM and the 30 end with minor groove binder
(MGB) was synthesized by Applied Biosystems Inc. (ABI,
Life Technologies). AgPath-IDTM One-Step RT-PCR
reagents (Life Technologies) were used for all tests. The test
was performed in 96-well plates on ABI SDS7900ht with a
final volume of 25 ll per well containing 19 RT-PCR buf-
fer, 0.5 lM forward primer, 0.5 lM reverse primer, 0.2 lM
probe, 19 RT enzyme mix and 5 ll RNA template. The
thermal cycler was programmed for 50°C for 30 min, 95°C
for 15 min for the RT step and 95°C for 10 s, 60°C for
1 min for the amplification step which was repeated 45
times. The threshold cycle (Ct) was determined for each
sample and positive controls. Ct values <35.99 were consid-
ered positive. Amplification with Ct value between 35.99
and 40.00 and or low curve to the threshold sample was
considered suspicious or doubtful, while Ct values >40 were
considered negative.
Detection of viral RNA using FMDV IRES TaqMan rRT-
PCR was carried out according to published protocols (Reid
et al., 2002; Anonymous, 2012) with some modifications.
The forward primer FMDV SA-IR-219-246F: 50-CA
CYTYAAGRTGACAYTGRTACTGGTAC-30 and reverse
primer FMDV SA-IR-315-293R: 50-CAGATYCCRAGTG
WCICITGTTA-30 were custom made by Invitrogen. The
FMDV TaqMan probe (FMDV SAmulti2-P-IR-292-269R:
50-CCTCGGGGTACCTGAAGGGCATCC-30) labelled on
the 50 end with 60FAM and the 30 end with MGB was synthe-
sized by Applied Biosystems Inc. (ABI, Life Technologies).
AgPath-IDTM One-Step RT-PCR reagents (Life Technolo-
gies) were used for all tests. The test was performed in 96-
well plates on ABI SDS7500 with a final volume of 25 ll per
well containing 19 RT-PCR buffer, 1.25 ll of 18 lM for-
ward primer, 1.25 ll of 18 lM reverse primer, 1 ll of 5 lM
probe, 19 RT enzyme mix and 5 ll RNA template. The
thermal cycler was programmed for 45°C for 10 min, 95°C
for 10 min for the RT step and 95°C for 15 s, 60°C for 45 s
for the amplification step which was repeated 45 times. The
Ct value was determined for each sample and positive con-
trols. Ct values <35.99 were considered positive. Amplifica-
tion with Ct value between 35.99 and 40.00 and or low curve
to the threshold sample was considered suspicious or doubt-
ful, while Ct values >40 were considered negative.
Viral antigen detection
A double antibody sandwich (DAS) ELISA was used to
detect FMDV present in samples according to a previously
described protocol (Moniwa et al., 2012). Average OD val-
ues >0.1 were considered positive.
Detection of FMDV antigen using a lateral flow device
(LFD), the SVANODIP FMDV-Ag (Boehringer Ingelheim
Svanova, Uppsala, Sweden) was carried out according to
the manufacturer’s instructions.
Detection of FMDV antigen using the in-house FMDV
serotype O specific LFD was carried out as described in
Yang et al. (2013).
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Virus neutralization test
Detection of neutralizing antibodies for serotype O was
performed on IBRS 2 cells according to a protocol devel-
oped at the NCFAD. For screening purposes, 1/4 dilution
of serum in diluent (MEM-a containing 50 lg/ml genta-
mycin and 2 mM L-glutamine) was added to three wells of
a tissue culture microtitre plate. Two wells were used for
the test, and the third well was used as a serum toxicity
control. For the determination of virus neutralization test
(VNT) titre, three columns of eight 2-fold dilutions of
serum starting from 1/4 were needed. Similarly, two wells
of each dilution were used for the test and the third well
used as a serum toxicity control. To each test well contain-
ing 25 ll of diluted serum, an equal volume of culture
medium (diluent with 10% foetal bovine serum) contain-
ing challenge virus (100 TCID50) was added. Culture med-
ium alone was added to serum toxicity control wells.
Positive and negative control sera were included for each
assay.
A back titration of the challenge virus was also per-
formed to confirm the titre used. Plates were incubated for
60  5 min. at 37  2°C in a humidified 5% CO2 incuba-
tor. IBRS2 cells (50 ll at 1 9 106 cells/ml) were then added
to all wells and the plates incubated at 37  2°C in a
humidified 5% CO2 incubator for 2–3 days. Serum samples
inhibiting cytopathic effect (CPE) in at least 50% of virus-
infected wells were considered positive. The VNT titre was
determined as the reciprocal of the serum dilution inhibit-
ing CPE in at least 50% of virus-infected wells.
Detection of serum antibodies against FMDV structural
proteins
Antibodies against FMDV serotype O structural proteins
(SP) were detected using four assays: the in-house solid
phase competitive FMDV serotype O antibody ELISA
(SPO-ELISA-IH) from the NCFAD, Winnipeg, Canada, and
the commercially available ELISAs PrioCHECKFMDV-O
antibody detection ELISA (SPO-ELISA-PR) from Life Tech-
nologies (formerly Prionics), Lelystad, The Netherlands, the
ID SCREENFMD type O competition ELISA (SPO-
ELISA-IV) from ID-Vet, Montpellier, France, and the
FMDV serotype O Solid Phase Competitive ELISA (SPO-
ELISA-IZ) from IZSLER, Brescia, Italy.
The SPO-ELISA-IH detects anti-serotype O FMDV anti-
bodies in test sera. Briefly, 96-well Maxisorp microplates
were coated overnight at 4°C with 100 ll per well of an
optimal dilution of rabbit anti-FMDV serotype O serum in
coating buffer (0.06 M carbonate buffer, pH 9.6  0.05).
Next, the plates were blocked with 100 ll of blocking/dilu-
tion buffer [5% normal rabbit serum, 10% normal bovine
serum in 0.01 M phosphate-buffered saline containing
0.05% Tween, pH 7.2  0.1 (PBST)] at 37°C on an orbital
incubator shaker. After 1 h blocking, plates were washed
five times with PBST followed by the addition of 100 ll per
well of FMDV serotype O antigen diluted to optimal con-
centration in blocking/dilution buffer. Plates were incu-
bated for 1 h at 37°C on an orbital incubator shaker.
After washing, 50 ll of 1/5 dilution of test serum and
controls was added to each well, immediately followed by
50 ll of diluted guinea pig anti-FMDV serotype O serum.
The plates were again incubated for 1 h at 37°C on an orbi-
tal incubator shaker. Plates were washed, 100 ll per well of
polyclonal donkey anti-guinea pig IgG (H&L) conjugated
to horseradish peroxidase diluted in blocking/diluent buffer
added and incubated for 1 h at 37°C on an orbital incuba-
tor shaker.
After washing, 100 ll of o-phenylenediamine dihydro-
chloride (OPD) substrate was dispensed into each well and
incubated for 10 min at room temperature. The OPD col-
our change reaction was stopped with 50 ll of 2 M sulphu-
ric acid. The optical density (OD) of each well of the plate
was determined on a microplate reader at 490 nm. Assay
ODs were corrected for background by subtracting average
OD of eight wells containing substrate and stop solution
alone. Results for test sera were expressed as a per cent inhi-
bition (PI) of signal strength. The PI value for each sample
was calculated by the following formula: PI = (100  mean
OD of 2 replicate test samples/(mean OD of the 4 replicate
target standards) 9 100. Based on the testing of over 900
cattle field sera and over 600 porcine field sera from an
FMDV-free country (Canada) and the frequency distribu-
tion of their PI values, samples were considered positive if
PI ≥ 50%.
The SPO-ELISA-PR, a competitive ELISA, was per-
formed according to the manufacturer’s instructions. Test
results were derived by the following formula: PI = 100 
(test sample OD/negative reference serum OD) 9 100.
According to the manufacturer’s evaluation data, samples
were considered positive if the PI value was ≥50%.
The SPO-ELISA-IV, a competitive ELISA, was performed
according to the manufacturer’s instructions. Test results
were calculated as follows: S/N% = 100 9 (test sample OD –
positive control OD)/(negative control OD – positive con-
trol OD). According to the manufacturer’s evaluation data,
samples with S/N% ≤35% were considered positive, >45%
negative and between 35% and 45% doubtful. In order to
make these competitive ELISA results comparable to other
competitive ELISA results, per cent inhibition (PI) was cal-
culated: PI% = 100 – S/N%., resulting in samples with PI%
≥65% being positive, <55% being negative and between
55% and 65% doubtful. For simplicity reasons, we used a
55% cut-off and no doubtful range.
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The SPO-ELISA-IZ, a competitive ELISA, was performed
according to the manufacturer’s instructions. Test results
were derived by the following formula: PI = 100  (test
sample OD/negative reference serum OD) 9 100. Accord-
ing to the manufacturer’s evaluation data, samples were
considered positive if the PI value was ≥70%.
Detection of serum antibodies against FMDV non-
structural proteins
Antibodies against NSPs were detected using four NSP-
ELISAs and a LFD.
The in-house 3ABC-ELISA (NSP-ELISA-IH) is a com-
petitive ELISA directed towards antibodies against the
FMDV 3ABC polypeptide, which is a NSP. It uses a recom-
binant 3ABC protein with a 5-histidine fusion tag as anti-
gen (Moniwa et al., 2012). The assay was performed as
previously described (Moniwa et al., 2012). Test results
were derived by the following formula: PI = [(negative ref-
erence serum OD)  test sample OD)/(negative reference
serum OD  positive reference serum OD)] 9 100. Based
on the testing of over 500 bovine, ovine and porcine field
sera from an FMDV-free country (Canada) and the fre-
quency of distribution of their PI values, samples were con-
sidered positive if the PI value was ≥50%.
The commercially available PrioCHECK FMDV NS
ELISA (NSP-ELISA-PR), a blocking ELISA, was performed
according to the manufacturer’s instructions (Life Technol-
ogies, Lelystad, The Netherlands). Test results were derived
by the following formula: PI = 100  (test sample OD/neg-
ative reference serum OD) 9 100. According to the manu-
facturer’s evaluation data, samples were considered positive
if the PI value was >50%.
The commercially available Anigen FMD NSP Ab ELISA
(NSP-ELISA-BN), a competitive ELISA, was performed
according to the manufacturer’s instructions (BioNote, Gy-
eonggi-do, Korea). Test results were derived by the follow-
ing formula: PI = [1  (test sample OD/negative reference
serum OD)] 9 100. According to the manufacturer’s eval-
uation data, samples were considered positive if the PI
value was >50%.
The commercial IDEXX FMD 3ABC Ab Test (NSP-
ELISA-ID), an indirect ELISA, was performed according to
the manufacturer’s instructions (IDEXX, Westbrook, ME,
USA). Test results were derived by the following formula: %
S/P = 100 9 (sample OD  negative control OD)/(positive
control OD  negative control OD). According to the man-
ufacturer’s evaluation data, samples were considered positive
if the S/P value was ≥30%, negative if the S/P value <20%,
and suspect if the S/P value was between 20% and 30%.
The Anigen Rapid FMD NSP Ab Test Kit (NSP-penside
test) was used according to manufacturer’s instructions
(BioNote, Inc, Gyeonggi-do, Korea).
Histopathology and immunohistochemistry
Fixed tissues were routinely processed, cut and stained with
haematoxylin and eosin (H&E) for histopathologic exami-
nation. For immunohistochemistry, 5 lm sections were
cut, air dried overnight and placed into a 60°C oven for
1 hour. The deparaffinized and rehydrated sections were
quenched for 10 min in aqueous 3% hydrogen peroxide,
rinsed in MilliQ water and placed into Tris-buffered saline
plus Tween (TBST) for 5 min. For the monoclonal anti-
body, epitopes were retrieved using low pH Glyca (Bioge-
nex, Freemont, CA, USA) in a decloaking chamber
(Biocare Medical, Concord, CA, USA). Sections were
loaded from a TBST bath onto the DakoCytomation auto-
stainer and incubated with mAb F8-3Bp (NSP) or mAb
F14-12SA (structural protein) at a dilution of 1 : 100 or
1 : 800, respectively, for 1 h. The sections were incubated
for 30 min using the Envision + anti-mouse-HRP polymer
kit (Dako, Carpinteria, CA, USA) followed by a TBST rinse.
Diaminobenzidine was used as the substrate chromogen,
and the slides were counterstained with Gill’s haematoxy-
lin.
Statistical methods
Diagnostic specificities (DSP) and 95% confidence intervals
(CI) were calculated using the software Epitool ‘test evalua-
tion against a gold standard’ (Sergeant ESG: 2009, Epitools
epidemiological calculators. AusVet Animal Health Services
and Australian Biosecurity Cooperative Research Centre
for Emerging Infectious Disease. Available at: http://epi
tools.ausvet.com.au).
Results
Clinical observations
Rectal temperatures did not show any significant changes
in the red deer following primary FMDV inoculation. The
average rectal temperature for all deer before inoculation
was 38.8°C  0.3°C, and 39.0°C  0.6°C after inocula-
tion. Likewise, no significant temperature changes were
observed in red deer re-inoculated at dpi 14 (data not
shown).
Only one of the 10 red deer, animal 1103, showed obvi-
ous clinical signs of FMD. This deer had mild signs of
lameness beginning on dpi 6. In addition, there were two
erosions (about 2 mm wide) on the underside of the ton-
gue apparently due to ruptured vesicles (Fig. 1a). By dpi
12, the tongue lesions had almost healed (Fig. 1b) and heal-
ing was complete at dpi 16 (Fig. 1c).
The development of foot lesions in deer 1103 started
at dpi 6 with a softening and apparently fluid-filled coro-
nary band on the right hind limb (Fig. 1d). By dpi 9, the
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coronary band lesion was blanched, soft and fluid filled in
one area while in another area the vesicle had ruptured
leaving a brownish open wound (Fig. 1e). At dpi 12, the
coronary band lesions became more extensive (Fig. 1f). By
dpi 16, the foot lesion had begun to heal (Fig. 1g). How-
ever, at dpi 21 the lesion apparently got worse possibly due
to secondary bacterial infection (Fig. 1h). At dpi 26, mild
lameness was observed and the lateral claw of the right hind
limb was apparently retracting beginning at the caudal por-
tion (Fig. 1i). Nevertheless, at dpi 29 when this deer was
euthanized, the foot lesions had almost healed leaving
behind dry wart-like crusts (Fig. 1j).
Mild clinical signs were also observed in most of the deer
starting at dpi 6, but these were inconclusive. Such signs
included mild lameness and apparent swelling of the coro-
nary band, but these changes never progressed to identifi-
able lesions. However, deer 1105 had a 2 mm wide vesicle
on the underside of the tongue on dpi 5 (Fig. 1k) and rapid
respiration on dpi 6 which returned to normal on dpi 7. By
dpi 9–14, eight deer except 1103 had returned to normal.
Re-inoculation by intramuscular injection did not induce
any disease in the six deer that were re-inoculated. How-
ever, at dpi 21 deer 1101 had erosion on the inside of the
cheek which could have been due to a ruptured vesicle
(Fig. 1l).
Pathology
Necropsy findings were unremarkable in all animals except
for the foot lesion described above in deer 1103 and multi-
focal coalescing haemorrhages of the soft palate in deer
1100. Microscopic examination was performed on tissues
from deer 1097, 1100 and 1103. For deer 1097 euthanized
at dpi 5, only non-specific changes including mild haemor-
rhage and neutrophil infiltration of the cervical lymph node
were observed. In deer 1100, there was mild haemorrhage
and perivascular accumulation of mononuclear inflamma-
tory cells in the subepithelial connective tissue of the palate
(a) (b) (c) (d)
(e)
(i) (j) (k) (l)
(f) (g) (h)
Fig. 1. Gross lesions in FMDV-inoculated red deer. (a) ventral surface of tongue of deer 1103 at 6 days post-inoculation (dpi 6) showing two erosions
(black arrows point to the lesions); (b) advanced healing of the same tongue lesions in A at dpi 12; (c) completely healed tongue at dpi 16; (d) swelling
of coronary band of the hoof of deer 1103 (white arrow) at dpi 6; (e) blanching of a fluid-filled vesicle (red arrow) and a ruptured vesicle (red arrow
head) at dpi 9; (f) wound left behind by ruptured coronary band vesicle (white arrow) at dpi 12; (g) coronary band lesion apparently starting to heal at
dpi 16; (h) coronary band wound apparently worsened possibly by secondary bacterial infection at dpi 21; (i) retraction of the hoof at dpi 26; (j) healed
foot lesion at dpi 29; (k) vesicle on the tongue of deer 1105 at dpi 5; (l) possible erosion on the inner cheek of deer 1100 at dpi 21.
© 2015 The Authors. Transboundary and Emerging Diseases Published by Blackwell Verlag GmbH • Transboundary and Emerging Diseases. 64 (2017) 213–225218
Foot-and-Mouth Disease in Red Deer R. Kittelberger et al.
which may have been related to the probang procedure.
For deer 1103, no significant microscopic findings were
observed. Immunohistochemistry was performed on tissues
from deer 1100 and 1103 using antibody F14-12SA, and
FMDV antigen could not be detected. Additionally, tissues
from animal 1103 were run using antibody F8-3Bp and
FMDV antigen was not detected.
Detection of viral RNA by rRT-PCR and of virus by
FMDV isolation
The presence of FMDV in samples from infected deer was
tested by both 3D and IRES rRT-PCR and by virus isola-
tion. Except for a few samples, data from both rRT-PCRs
were almost identical (Table 1).
Most positive results in all three tests were from nasal
swabs, such as deer 1100 on dpi 1 and 4, deer 1103 on dpi 3
and 6, deer 1104 on dpi 2 and 5, and deer 1107 on dpi 3.
Deer 1103 was also positive in both rRT-PCRs but negative
by virus isolation in serum on dpi 3 and in oral swab dpi
16. The oral swab samples from deer 1102 at dpi 12 and
probang sample from deer 1103 at dpi 6 had detectable
FMDV RNA by 3D rRT-PCR but were negative by IRES
rRT-PCR. The reverse was true for the serum samples from
deer 1104 at dpi 2 with FMDV RNA detection by IRES but
not by 3D rRT-PCR.
Only two samples (oral swab form deer 1104 at dpi 2
and nasal swabs from deer 1102 at dpi 3) with Ct ≥36 con-
tained infectious virus. Interestingly, virus could be isolated
from three samples negative for FMDV genome (probang
samples from deer 1100 at dpi 4 and 1104 at dpi 2, blood
from deer 1104 at dpi 5). Most of the samples required two
passages on LK cells before infectious virus could be
detected.
Vesicular fluid and all swabs of lesions (tongue at dpi 6
and coronary band at dpi 12 and 16) from deer 1103 were
positive for FMDV genome with comparable results for the
3D and IRES rRT-PCR (Table 2). However, infectious
virus could only be isolated from vesicular fluid and tongue
lesion swabs (Table 2).
Tissues collected at necropsy, including lymph nodes,
soft palate and tonsils, from all but one animal were nega-
tive for FMDV genome by rRT-PCR. Tonsil from deer
1103, euthanized at dpi 29, tested positive for FMDV gen-
ome by rRT-PCR with Ct = 30.7 by 3D and 33.7 by IRES
rRT-PCR. However, infectious virus or viral antigen could
not be isolated or detected by immunohistochemistry,
respectively.
Detection of viral antigen
The in-house DAS ELISA was used to confirm the presence
of FMDV in supernatants from LK cell cultures for virus
isolation. As shown in Table 3, all but one of the superna-
tants from cell cultures showing CPE either after the 1st or
2nd passage, were positive for FMDV antigen by the DAS-
ELISA. Although the vesicular fluid isolate tested negative
by DAS-ELISA twice, virus presence was confirmed by
rRT-PCR.
Rapid antigen detection tests were performed using an
in-house LFD test for FMDV serotype O and the commer-
cially available Svanodip FMDV-Ag test. Testing was lim-
ited to samples that were positive or suspicious for the
presence of FMDV genome by rRT-PCR.
Both tests detected cell culture-derived FMDV serotype
O UKG 11/2001 and O SKR 4/2010 used as strong positive
controls. However, from the deer samples, only vesicular
fluid obtained at dpi 9 from deer 1103 produced a very
faint band at the test line with the in-house LFD test and
was negative in the commercial test.
Detection of FMDV antibodies after initial inoculation
Of the 10 experimentally inoculated red deer, only animal
1103 showed an antibody response after the initial inocula-
tion (Fig. 2a,b). Neutralizing antibodies were detected from
dpi 9 onwards with titres in the VNT peaking at 1/256 at
dpi 12 (Fig. 2b). Thereafter, titres dropped but remained
low positive over the remainder of the trial period with a
slight peak at dpi 23.
The antibody response in the four NSP-ELISAs was
variable (Fig. 2a). The NSP-ELISA-IH and the NSP-
ELISA-PR performed equally well with antibody detec-
tion from dpi 14 onwards, but the NSP-ELISA-PR reac-
tion was already just below the cut-off at dpi 12.
Antibody levels peaked at dpi 16 and slowly declined
over the course of infection. The NSP-ELISA-BN and the
NSP-ELISA-ID performed relatively poorly. NSP-ELISA-
BN detected samples as positive at one time point only
(dpi 16) and NSP-ELISA-ID at two time points (dpi 19
and 21).
The NSP antibody LFD penside test detected antibodies
earlier in whole blood as revealed by a faint band on dpi 14,
while the earliest detection of antibodies in serum was at
dpi 16 (Fig. 3). Antibodies could be detected up until dpi
29 when the animal was euthanized.
Serotype specific antibodies were detected by the SPO-
ELISA-IH and the SPO-ELISA-PR from dpi 9 and 12,
respectively (Fig. 2b). Data from both tests were almost
identical, except that the SPO-ELISA-PR had not yet
crossed the cut-off level at dpi 9, even though the PI was on
the increase and close to the cut-off. SPO-ELISA-IV
showed a similar increase of sero-positivity to the previous
assays but with lower PI values. The SPO-ELISA-IZ lagged
behind and only showed positive results from dpi 19
onwards.
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Detection of FMDV antibodies after re-inoculation
For the reason that only deer 1103 had shown an antibody
response from dpi 9 onwards, six of the red deer were
re-inoculated intramuscularly with the same FMDV strain
that had been used initially but at a higher dose at dpi 14.
Results are shown in Fig. 2c–h for the six animals. None of
the re-inoculated animals staged an antibody response to
NSP. None of these animals became positive in rRT-PCR
or by virus isolation after re-inoculation. Nevertheless, all
six animals became positive for SP serotype O antibodies
(Fig. 2c–h) and in the VNT.
Five of the animals became positive in the VNT at
dpi19/5 and one animal, deer 1106, became positive at dpi
21/7. In the SPO-ELISA-IH and SPO-ELISA-PR, the
strongest SPO antibody responses over the course of re-
inoculation were observed for each animal. Antibody
activities were comparable for both ELISAs, showing simi-
lar patterns over the experimental period. Each of the six
animals became positive in both ELISAs from dpi 19/5
onwards. SPO-ELISA-PR was slightly weaker than
SPO-ELISA-IH in deer 1101 (Fig. 2d) but otherwise com-
parable.
The SPO-ELISA-IV showed comparable pattern to the
previous SPO-ELISAs in deer 1098, 1101 and 1102
(Fig. 2c–e) with slightly lower PI values. Nevertheless, it
failed to detect deer 1105, 1106 and 1107 (Fig. 2f–h) as
positive, even though the PI values were increasing over
time. The SPO-ELISA-IZ generally did not identify samples
as positive over the course of inoculation in any of the six
re-inoculated deer. Generally, the PI levels during the phase
prior to rising PI values were rather high at around 40%.
Even if there was a rise of PI values in the SPO-ELISA-IZ, it
was not much and did not rise above the relatively high
cut-off value of 70%.
Diagnostic specificities
The diagnostic specificities (DSP) of most of the commer-
cial test methods used were determined at the AHL, New
Zealand, using samples from non-infected deer from local
slaughter houses (Table 4). Generally, DSP values were
Table 1. FMDV RNA detection in samples from infected red deer by real-time reverse transcriptase polymerase chain reaction and by virus isolation
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high for every test method, well above 99% or above 88%
for the lower 95% CI.
Discussion
Foot-and-mouth disease virus has been shown to infect
cervids such as reindeer, moose and deer, including white
tailed deer (McVicar et al., 1974; Haigh et al., 2002; Dun-
bar et al., 2009; Arzt et al., 2011; Moniwa et al., 2012).
FMDV is transmitted mainly by direct contact between an
infected and a susceptible animal and most often entry is
through the pharyngeal region and upper respiratory tract
but can also occur through cuts and abrasions in skin and
mucosa (Alexandersen et al., 2003b). Clinical signs of
FMD in deer are varied, with red deer and fallow deer
showing milder signs compared to white tailed deer, roe
deer and muntjac deer (Forman and Gibbs, 1974; Gibbs
et al., 1975; Moniwa et al., 2012). In the current study, red
deer were inoculated intranasal, as close as possible to nat-
ural infection. Only one of ten red deer developed the typi-
cal foot lesions of FMD, which were confined to just one
foot. In addition, fever and tongue lesions in this animal
were mild.
Even though few other animals had the virus in oral and
nasal swabs at dpi 1–5 by both rRT-PCR and virus isola-
tion, only the animal with clinical disease had FMDV RNA
levels considered positive by rRT-PCR in serum. However,
transient viraemia based on infectious virus isolation was
also detected in another deer, but this was not matched by
clinical disease. This could mean that the genomes were not
detected in the other deer due to bad timing (animals could
not be sampled daily), low sensitivity or low viral load. In
contrast, in a previous study with white tailed deer at the
NCFAD, most of the animals inoculated by the intranasal
route developed viraemia at dpi 1–4 and severe disease even
at lower doses of the challenge virus (Moniwa et al., 2012).
Based on the current study’s data, FMD in red deer was
mild and only one animal truly became infected. Despite
failure to isolate infectious virus, the apparent persistence
of FMDV RNA (up to dpi 29) in the tonsils of the red deer
that developed clinical disease is indicative of a possible
carrier state in red deer. In experimentally infected white
tailed deer, virus was not detected beyond dpi 28 (Moniwa
et al., 2012) but in other reports virus detection in white
tailed deer lasted for up to 11 weeks after infection (McVic-
ar et al., 1974).
The detection of antibodies to FMDV NSP is often used
to confirm a history of active infection with replication of
virus and systemic spread. This also serves as a means of
distinguishing vaccinated from infected animals (DIVA) as
vaccinated animals lack antibodies to FMDV NSP (Clavijo
et al., 2004). In the current experiment, only the one deer
that had transient viraemia and developed clinical FMD
lesions (1103) was positive for antibodies to FMDV NSP.
Furthermore, using serotype O ELISA, antibodies to whole
virus antigen were detected in the same animal following
the primary inoculation. In addition, the VNT, which is a
functional assay, detected neutralizing antibodies only in
the one deer following the primary inoculation. These
results confirmed that just one deer had a systemic FMDV
Table 2. FMDV RNA detection by real-time reverse transcriptase poly-
merase chain reaction and by virus isolation in deer 1103
Sample type dpi
3D rRT-PCR
Ct value
IRES rRT-PCR
Ct value VI
Tongue lesion swab 6 30.3 28.6 +
Vesicular fluid 9 27.7 27.1 +
Foot lesion swab 9 24.6 25.0 
Foot lesion swab 12 35.6 37.3 
Foot lesion swab 12 27.3 26.1 
Foot lesion swab 12 30.1 29.0 
Foot lesion swab 16 31.4 31.1 
Foot lesion swab 16 29.8 29.2 
Numbers represent the threshold cycle (Ct) values for FMDV RNA detec-
tion by real-time reverse transcriptase polymerase chain reaction (rRT-
PCR) targeting the 3D or IRES genes.
VI, virus isolation; + indicates isolation of infectious virus from the sam-
ple; means no infectious virus was recovered; dpi = days post-inocu-
lation.
Table 3. Results of the double antibody sandwich ELISA on virus iso-
lated from samples from FMDV-infected red deer
Deer ID dpi Sample type
Virus isolation result
DAS-ELISA
1st
passage
2nd
passage OD values
1100 1 Nasal swab Positive 1.8
1100 4 Nasal swab Positive 2.2
1100 4 Probang Negative Positive 2.3
1102 3 Nasal swab Negative Positive 2.1
1103 3 Nasal swab Negative Positive 2.0
1103 6 Nasal swab Positive 2.2
1103 6 Oral swab Positive 2.0
1103 6 Probang Negative Positive 1.5
1103 6 Tongue lesion
swab
Negative Positive 2.1
1103 9 Vesicular fluid Positive 0
1104 2 Nasal swab Positive 2.0
1104 2 Oral swab Negative Positive 2.2
1104 2 Probang Negative Positive 2.3
1104 5 Nasal swab Positive 1.5
1104 5 Oral swab Negative Positive 2.3
1104 5 Blood Negative Positive 2.3
DAS, double antibody sandwich; OD, optical density; OD > 0.1 is con-
sidered positive; ID, animal identification number; dpi, days post-inocu-
lation.
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
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infection sufficient to induce an immune response. Intra-
muscular re-inoculation of the deer that had no clinical
signs or no detectable antibodies at dpi 14 induced neither
clinical disease nor antibodies to FMDV NSP by the time
the experiment was terminated.
Intramuscular inoculation can lead to infection in sus-
ceptible species as the virus spreads to the blood stream
and also reaches epithelial cells (Alexandersen et al.,
2003b). Such cells are most abundant in the stratified squa-
mous epithelium of the tongue, in and round the mouth,
and in the skin (Zhang and Alexandersen, 2004). With the
high dose of the inocula used for re-inoculation of six ani-
mals, it was expected that some virus would get into the
blood and spread to more susceptible sites. Therefore, the
absence of disease following re-inoculation either means
low susceptibility of red deer to FMDV or suggests that the
initial inoculation might have induced specific immunity,
including cell mediated immunity, despite the absence of
clinical disease. Such an immune response would delay
and/or prevent virus replication following a repeat infec-
tion. This hypothesis is consistent with the antibody reac-
tion observed after the second, but not the first,
inoculation as discussed.
Contrary to the FMDV NSP response, intramuscular re-
inoculation with FMDV induced a rapid rise in neutralizing
antibodies and serotype O specific antibody response to
whole virus antigen, with all 6 re-inoculated deer testing
positive at day 5 after re-inoculation. This suggests that the
intramuscular inoculum, instead of leading to infection,
possibly served mainly as a source of antigen for the
immune system. The rapid response at dpi 5 compared to
the one animal 1103 that sero-converted following the ini-
tial inoculation could be a consequence of the route of
inoculation and the high inoculum (108 TCID50 per ani-
mal). Furthermore, there is a high possibility that the
immune system had been primed by the initial inoculation.
Fig. 2. Antibody detection in seven red deer after experimental inoculation (a and b clinically infected deer 1103) and re-inoculation (c–h). (a) Deer
1103. Antibody reaction in four non structural protein (NSP) ELISAs during the course of experimental infection. NSP-ELISA-IH = in house blocking
ELISA; NSP-ELISA-BN = commercial competitive ELISA from BioNote; NSP-ELISA-PR = commercial blocking ELISA from Life Technologies; NSP-ELISA-
ID = commercial indirect ELISA from IDEXX. % S/P = ratio of optical density of sample/optical density of positive control in percent. (b–h) Antibody
reactions in the virus neutralization test (VNT) and four FMDV structural protein serotype O (SPO)-specific ELISAs: SPO-ELISA-IH = in-house competi-
tive ELISA, SPO-ELISA-PR = commercial blocking ELISA (Life Technologies), SPO-ELISA-IV = commercial competitive ELISA (ID-VET), SPO-ELISA-
IZ = commercial competitive ELISA (IZSLER) for the detection of serotype O specific antibodies. (a, b) Deer 1103, experimentally infected. (d–h) Deer
1098, 1101, 1102, 1105, 1106 and 1107. These deer were re-inoculated with a FMD serotype O virus. Dpi, day post-inoculation.
Fig. 3. Detection of antibodies by a lateral flow device (pen-side test)
against non-structural viral proteins in serum and whole blood during
the course of experimental infection in deer 1103. DPI, days post-inocu-
lation.
Table 4. Diagnostic specificities of a number of commercial FMDV screening tests
Test Method
Number
of deer
tested Sample type
Samples
positive DSP %
DSP %
Lower CI 95%
DSP %
Upper CI 95%
3D rRT-PCR 200 Nasal swab 0 100.00 98.17 100.00
3D rRT-PCR 200 Serum 0 100.00 98.17 100.00
IRES rRT-PCR 200 Nasal swab 0 100.00 98.17 100.00
IRES rRT-PCR 200 Serum 0 100.00 98.17 100.00
NSP-ELISA-PR 950 Serum 1 99.89 99.41 100.00
SPO-ELISA-PR 950 Serum 2 99.79 99.24 99.97
SPO-ELISA-IZ 950 Serum 2 99.79 99.24 99.97
SPO-ELISA-IV 950 Serum 0 100.00 99.61 100.00
NSP-LFD Bionote 950 Serum 0 100.00 99.61 100.00
DSP, diagnostic specificity; CI, confidence interval.
© 2015 The Authors. Transboundary and Emerging Diseases Published by Blackwell Verlag GmbH • Transboundary and Emerging Diseases. 64 (2017) 213–225 223
R. Kittelberger et al. Foot-and-Mouth Disease in Red Deer
While the FMDV IRES TaqMan rRT-PCR was carried
out by following the method described in the OIE manual
(Anonymous, 2012), the FMDV 3D TaqMan rRT-PCR was
carried out according to a published protocol (Moniwa
et al., 2007). Nevertheless, the primers and probe for the
3D gene as described in this study have been validated for
use in FMD diagnosis at the NCFAD (Moniwa et al., 2007)
and have been used with external proficiency panels from
the World Reference Laboratory for FMD, Pirbright, with
no discrepancy to the OIE rRT-PCR assays over the years.
Regarding the comparison of test methods, both the
FMDV 3D and IRES rRT-PCR were to a large extent
equally good for the detection of FMDV RNA. In addition,
most of the samples positive by rRT-PCR were also positive
by virus isolation. However, most of the lesion swabs had
Ct ≤35.99, but no infectious virus was recovered from
them. On the other hand, some samples with Ct ≥36 by
rRT-PCR were positive by virus isolation. Virus isolation is
considered the gold standard for detecting the presence of
FMDV in clinical material (Moniwa et al., 2012). Based on
the data reported here, more samples from infected red
deer tested positive by rRT-PCR than by virus isolation. It
is not unusual, for whatever reason, to see discrepancies in
some samples. This has been observed before (Reid et al.,
2002; Alexandersen et al., 2003a,b; Zhang and Alexander-
sen, 2004). With virus isolation being laborious and time
consuming, requiring 2–4 days to obtain results, and with
the data available, rRT-PCR assays would play a central role
during an FMD incursion as screening methods for red
deer.
For rapid antigen detection, only the NCFAD in-house
LFD and not the commercial pan-reactive LFD (Svanodip)
detected FMDV antigen in vesicular fluid from the infected
red deer. However, the band was very faint and in the field,
such a result would probably be considered inconclusive,
necessitating further testing in the laboratory. It is worth
noting that, because of the small volume recovered from
the vesicles, vesicular fluid was diluted in PBS. Therefore,
an undiluted sample would have likely come up positive
on, at least, the NCFAD in-house LFD.
Sufficient samples were obtained from the one infected
animal and the six re-inoculated animals to compare the
performance of the SPO-ELISAs to each other and to the
VNT. The SPO-ELISA-IH and the commercial SPO-
ELISA-PR detected antibody responses with confidence
and comparable to the VNT. Unexpectedly, two commer-
cial SPO-ELISAs failed to detect some or most animals as
positive. Therefore, the SPO-ELISA-PR will be the choice
of screening ELISA for FMD preparedness for red deer.
There were limited positive samples for a comparison of
FMDV NSP-ELISAs obtained from one animal only. How-
ever, results from this one deer showed that the NSP-
ELISA-IH and the NSP-ELISA-PR detected anti-NSP
serum antibodies during the course of infection. The other
two ELISAs, NSP-ELISA-BN and NSP-ELISA-ID identified
most samples as negative that came up positive in the
other NSP-ELISAs. The NSP-ELISA-BN is a competitive
ELISA and was expected to perform at a similar level to
other NSP competitive/blocking ELISAs. A possible expla-
nation for this is the monoclonal antibody used, which
has specificity for one epitope of the NSP antigen. If this
one deer failed to make sufficient serum antibodies against
the specific epitope, the ELISA could fail to detect this ani-
mal as positive, even though it showed some antibody
reactivity below the cut-off level. The NSP-ELISA-ID is an
indirect ELISA and uses an anti-ruminant IgG-HRP con-
jugate. It may well be that this conjugate does not work as
well with deer antibodies as it does with cattle or sheep
IgGs.
Again, we were able to identify an ELISA, the NSP-
ELISA-PR, which can be used for FMD preparedness in
laboratories where the in-house ELISA is not readily avail-
able. As in other animal species, the antibody response to
NSPs appeared later than the antibody response to SPs
(Ryan et al., 2008).
The NSP antibody LFD test was comparable to the NSP-
ELISA-PR in terms of initial detection of serum antibodies
to FMDV NSP and duration of antibody detection. Consid-
ering that results can be acquired by this penside test within
minutes of obtaining samples, this test might be ideal for
rapid detection of antibodies in FMDV-infected red deer.
However, the sample size is too small to allow for any firm
conclusions.
In summary, the main aims of this study have been
achieved, such as providing sample material that could be
used for comparing FMD test method performance in red
deer, and in determining which readily available test meth-
ods could be used and should be maintained at laboratories
for FMD preparedness. The two rRT-PCR methods
detected animals harbouring the virus comparably to virus
isolation. The SPO-ELISA-PR and the NSP-ELISA-PR per-
formed comparably well to their in-house ELISA equiva-
lents and to the VNT. The NSP antibody detection LFD
showed potential for easy and early detection of FMDV
infection in the field using blood or serum. Finally, red deer
seem to be relatively resistant to FMDV infection.
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